Grants Awarded in 2019

Use of a Response-Adapted Ruxolitinib-Containing Regimen for the Treatment of Hemophagocytic Lymphohistiocytosis
Melissa Hines
St Jude Children's Research Hospital, Memphis, TN USA

Mapping and understanding the heterogeneity of Langerhans cell histiocytosis using single-cell analysis
Florent Ginhoux Singapore
Immunology Network (SIgN) / A*STAR, Singapore

Identification of a microRNA expression signature for diagnosis and monitoring of treatment response in Erdheim-Chester disease and its role in disease pathogenesis
Ofer Shpilberg
Assuta Medical Centers, Tel-Aviv, Israel

Transcriptional dysregulation of myeloid cells with MAP kinase pathway mutations
Matthew Collin
Newcastle University, Newcastle upon Tyne, UK

Excessive IL-10 Potentiates IL-18 to Cooperatively Drive Severe Secondary HLH/MAS-like Disease and Hyper-inflammaphagocytic Macrophage Polarization in Mouse Models.
Gang Huang
Cincinnati Children's Hospital Medical Center, Cincinnati, OH USA